Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, physician nephrology, ambulant treatment, and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an)

Fresenius Medical Care ( ($FMS) ) has provided an announcement. Fresenius Medical Care announced the appointment of Charles Hugh-Jones as the new G...

Fresenius Medical Care Appoints New Global Chief Medical Officer

The latest update is out from Focus Graphite ( ($TSE:FMS) ). Focus Graphite Inc. has successfully closed a $3.9 million bought deal offering, issui...

Focus Graphite Secures $3.9 Million in Bought Deal Offering

Foremost Lithium Resource & Technology Ltd ( ($TSE:FAT) ) has provided an update. Foremost Clean Energy Ltd. has successfully completed its 2025 di...

Foremost Clean Energy Completes 2025 Drill Program and Initiates Core Sampling at Jean Lake

Focus Graphite ( ($TSE:FMS) ) has shared an announcement. Focus Graphite Inc. has secured a $14.1 million non-repayable funding agreement with Natu...

Focus Graphite Secures $14.1M Federal Funding to Advance High-Purity Graphite Supply Chain

In a report released today, Sam England from Berenberg Bank maintained a Buy rating on Fresenius Medical Care AG & Co. KGaA, with a price target of...

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Buy from Berenberg Bank

An announcement from Focus Graphite ( ($TSE:FMS) ) is now available. Focus Graphite Inc. has appointed Dr. Sunho Kang, a renowned battery executive...

Focus Graphite Appoints Dr. Sunho Kang as Strategic Advisor to Enhance Battery Technology

An update from Foremost Lithium Resource & Technology Ltd ( ($TSE:FAT) ) is now available. Foremost Clean Energy Ltd. has received a three-year exp...

Foremost Clean Energy Secures Exploration Permit and Plans Gravity Survey at Turkey Lake Uranium Project

UBS analyst Graham Doyle maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €38.00. According to TipR...

UBS Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Barclays analyst Hassan Al-Wakeel maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €48.00. Accordin...

Barclays Sticks to Their Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

The latest update is out from Foremost Lithium Resource & Technology Ltd ( ($TSE:FAT) ). Foremost Clean Energy Ltd. has announced promising assay r...

Foremost Clean Energy Reports High-Grade Gold Success at Jean Lake

An update from Fresenius Medical Care ( ($FMS) ) is now available. On November 17, 2025, Fresenius Medical Care successfully placed a €500 million ...

Fresenius Medical Care Issues €500 Million Bond to Strengthen Financial Position

Foremost Lithium Resource & Technology Ltd ( ($TSE:FAT) ) just unveiled an announcement. Foremost Clean Energy Ltd. has successfully completed a 2,...

Market Cap	$13.32B	P/E Ratio	10.63
52W High	$30.46	52W Low	$22.05
Div Yield	78.7%	Payout Ratio	N/A
EPS Growth 3Y	0.0%	52W Position	18.4%
Overall Score	53	Value Score	80
Quality Score	34	Technical Score	45

EPS Current Est	$2.22	EPS Next Est	$2.45
EPS Growth Est	+10.4%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	FMS	$23.60	+0.94%	759.03K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	FMS	$23.60	+0.9%	759.03K
3
4
5
6

FMS

FMS

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an) Data in Excel

Get Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an) Data in Excel